Skip to ContentSkip to Navigation
About us Latest news News News articles

Molecular markers for diagnosis and prognosis in cervical neoplasia

18 May 2011

PhD ceremony: Mr. J.J.H. Eijsink, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Molecular markers for diagnosis and prognosis in cervical neoplasia

Promotor(s): prof. A.G.J. van der Zee, prof. H. Hollema, prof. G.H. de Bock

Faculty: Medical Sciences

 

Population-based screening has reduced the incidence of cervical cancer significantly in Western countries, but there is still room for improvement. A test based on detection of DNA methylation appears to be an attractive tool for cervical neoplasia screening because gene promoter methylation marks an early event in cervical carcinogenesis. In this thesis a methylation test for cervical cancer using four methylation markers was developed and evaluated. The test has the potential to detect 95% of cervical cancers and 65% of high-grade premalignant lesions. It was also shown that the methylation test is feasible on cervico-vaginal lavages obtained by a self-sampling device. A self-sampling approach may be a useful alternative screening strategy because 30% of the Dutch women do not attend the screening programme, and almost half of the cervical cancer patients are diagnosed in this population.

 

Last modified:13 March 2020 01.10 a.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 24 March 2025

    UG 28th in World's Most International Universities 2025 rankings

    The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...

  • 05 March 2025

    Women in Science

    The UG celebrates International Women’s Day with a special photo series: Women in Science.

  • 28 February 2025

    Vici grants for two UG/UMCG scientists

    The Dutch Research Council (NWO) has awarded Vici grants, worth up to €1.5 million each, to Merel Keijzer and Charalampos Tsoumpas This will enable the researchers to develop an innovative line of research and set up their own research group for...